Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends
What Are the Key Factors Driving Inactivated Polio And Rabies Vaccines Market Size and Growth?
The inactivated polio and rabies vaccines market size has grown strongly in recent years. It will grow from $2.16 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing vaccination campaigns, rising awareness about polio and rabies, government immunization programs, high incidence rates of polio and rabies in certain regions, and support from international health organizations.
The inactivated polio and rabies vaccines market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to advancements in vaccine technology, growing demand for vaccination in emerging markets, increased focus on global health security, government policies promoting vaccination, rising healthcare expenditure on preventive measures, etc. Major trends in the forecast period include increasing demand for combined polio and rabies vaccines, advancements in freeze-drying technology for vaccine stability, development of single-dose formulations for easier administration, advancements in cold chain logistics for improved vaccine distribution, growth in global immunization programs, and government-funded vaccination initiatives.
Claim your free report sample now:
What Are the Key Factors Contributing to Inactivated Polio And Rabies Vaccines Market Growth?
The growing demand for effective vaccination programs is expected to propel the growth of the inactivated polio and rabies vaccines going forward. A vaccination program is a planned effort by a group or government to give people vaccines to help protect them from diseases. Rising vaccination programs stem from stronger government efforts to prevent outbreaks, lower healthcare costs, and boost public health. Vaccination programs boost demand for inactivated polio and rabies vaccines by enhancing awareness, funding, and coverage in high-risk areas. Mass campaigns and routine immunizations led by governments and health bodies sustain consistent uptake. For instance, in April 2024, according to the Pan American Health Organization (PAHO), a US-based specialized agency, the 22nd Vaccination Week in the Americas (VWA) with the theme Engage now to protect your future GetVax launched, aiming to increase vaccination coverage, especially in underserved areas, by administering over 65 million doses. The initiative focused on combating misinformation and enhancing access to vaccines through community engagement and tailored campaigns. Therefore, the growing demand for effective vaccination programs is driving the growth of the inactivated polio and rabies vaccines market.
Which Segment Holds the Largest Share in the Inactivated Polio And Rabies Vaccines Market?
The inactivated polio and rabies vaccines market covered in this report is segmented –
1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine
2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations
3) By Distribution Channel: Government, Private
4) By Application: Pediatrics, Adults
Subsegments:
1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine
2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine
Which Emerging Trends Are Driving the Inactivated Polio And Rabies Vaccines Market?
Major companies operating in the inactivated polio and rabies vaccines market are focused on developing advanced products, such as killed virus rabies vaccines, to improve immunogenicity and meet the rising global demand for effective disease prevention. Killed virus rabies vaccines are formulated using rabies virus that has been rendered non-infectious through chemical or physical processes. These vaccines stimulate the immune system to produce protective antibodies without causing the disease, ensuring safety and effectiveness in both pre- and post-exposure prophylaxis. For instance, in April 2024, Sanofi, a UK-based pharmaceutical company, launched Verorab, an inactivated rabies vaccine, in the UK for pre-exposure and post-exposure prophylaxis of rabies in all age groups. The vaccine, licensed in the UK based on extensive clinical data from over 13,000 individuals, has been widely used in more than 80 countries. Verorab provides an effective immunization option for travelers to high-risk countries and for treatment after rabies exposure, with clinical trials showing strong immune responses and long-lasting protection.
Who Are the Emerging Players in the Inactivated Polio And Rabies Vaccines Market?
Major companies operating in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd.
Get the full inactivated polio and rabies vaccines market report here:
What Are the Regional Opportunities for Investment in the Inactivated Polio And Rabies Vaccines Market?
North America was the largest region in the inactivated polio and rabies vaccines market in 2024. The regions covered in the inactivated polio and rabies vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment